BioSavita Competitors and Similar CompaniesClear all

BioSavita's competitors and similar companies include Resverlogix, Lexicon Pharmaceuticals, ARCA biopharma and Benitec Biopharma.

	BioSavita BioSavita (formerly ApoLife) is a company that is focused on developing biological drugs and vaccines.	Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.	ARCA biopharma ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.	Benitec Biopharma Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy.
Founding Date	Founding Date 1994	Founding Date 2001	Founding Date 1995	Founding Date 2009	Founding Date 2001
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Plymouth, US HQ	Locations Calgary, CA HQ San Francisco, US	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more	Locations Westminster, US HQ Westminster, US	Locations Hayward, US HQ Melbourne, AU Louisville, US
Employees	Employees 10	Employees 19	Employees 20216% increase	Employees 940% decrease	Employees 14
Valuation ($)	Valuation ($) N/A	Valuation ($) 12.9 m	Valuation ($) 737.4 m	Valuation ($) 34.8 m	Valuation ($) 192 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $49.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $274k (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $50k (FY, 2025)	Gross profit $49.5m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($7.8m) (FY, 2025)	Net income ($50.3m) (FY, 2025)	Net income ($105.4m) (FY, 2025)	Net income ($37.9m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 3m	Total funding raised $ 10m	Total funding raised $ 244.7m	Total funding raised $ 7.2m	Total funding raised $ 36.3m